Letter to the Editor
Transfusion reaction to hyperimmune plasma in patients with severe COVID-19 infection
Reacción transfusional a plasma hiperinmune en pacientes con infección grave por COVID-19
Paloma Eugenia Edroso Jarne
, Herminia Lozano Gómez, Paula Abansés Moreno
Corresponding author
Servicio de Medicina Intensiva, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
Read
565
Timeswas read the article
15
Total PDF
550
Total HTML
Share statistics
array:24 [ "pii" => "S2387020621000723" "issn" => "23870206" "doi" => "10.1016/j.medcle.2020.11.011" "estado" => "S300" "fechaPublicacion" => "2021-03-26" "aid" => "5503" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2020" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2021;156:305" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0025775320308320" "issn" => "00257753" "doi" => "10.1016/j.medcli.2020.11.013" "estado" => "S300" "fechaPublicacion" => "2021-03-26" "aid" => "5503" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2021;156:305" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Editor</span>" "titulo" => "Reacción transfusional a plasma hiperinmune en pacientes con infección grave por COVID-19" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "305" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Transfusion reaction to hyperimmune plasma in patients with severe COVID-19 infection" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Paloma Eugenia Edroso Jarne, Herminia Lozano Gómez, Paula Abansés Moreno" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Paloma Eugenia" "apellidos" => "Edroso Jarne" ] 1 => array:2 [ "nombre" => "Herminia" "apellidos" => "Lozano Gómez" ] 2 => array:2 [ "nombre" => "Paula" "apellidos" => "Abansés Moreno" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2387020621000723" "doi" => "10.1016/j.medcle.2020.11.011" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020621000723?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775320308320?idApp=UINPBA00004N" "url" => "/00257753/0000015600000006/v1_202103100748/S0025775320308320/v1_202103100748/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2387020621000619" "issn" => "23870206" "doi" => "10.1016/j.medcle.2019.12.022" "estado" => "S300" "fechaPublicacion" => "2021-03-26" "aid" => "5071" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2021;156:306-7" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Granulocytic sarcoma: Study of two cases by high throughput sequencing" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "306" "paginaFinal" => "307" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Sarcoma granulocítico: estudio de dos casos mediante secuenciación masiva" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Andrea Espasa, Lurdes Zamora, Josep-Maria Ribera" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Andrea" "apellidos" => "Espasa" ] 1 => array:2 [ "nombre" => "Lurdes" "apellidos" => "Zamora" ] 2 => array:2 [ "nombre" => "Josep-Maria" "apellidos" => "Ribera" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775320300877" "doi" => "10.1016/j.medcli.2019.12.008" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775320300877?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020621000619?idApp=UINPBA00004N" "url" => "/23870206/0000015600000006/v1_202103200954/S2387020621000619/v1_202103200954/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2387020621000607" "issn" => "23870206" "doi" => "10.1016/j.medcle.2020.01.025" "estado" => "S300" "fechaPublicacion" => "2021-03-26" "aid" => "5070" "copyright" => "Elsevier España, S.L.U." "documento" => "article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Med Clin. 2021;156:302-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific letter</span>" "titulo" => "Antibody-mediated encephalitis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "302" "paginaFinal" => "304" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Encefalitis mediada por anticuerpos" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Francisco José Hernández Ramos, Alfredo Palomino García, María Dolores Jiménez Hernández" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Francisco José" "apellidos" => "Hernández Ramos" ] 1 => array:2 [ "nombre" => "Alfredo" "apellidos" => "Palomino García" ] 2 => array:2 [ "nombre" => "María Dolores" "apellidos" => "Jiménez Hernández" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775320300865" "doi" => "10.1016/j.medcli.2020.01.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775320300865?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020621000607?idApp=UINPBA00004N" "url" => "/23870206/0000015600000006/v1_202103200954/S2387020621000607/v1_202103200954/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Transfusion reaction to hyperimmune plasma in patients with severe COVID-19 infection" "tieneTextoCompleto" => true "saludo" => "Dear Editor:" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "305" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Paloma Eugenia Edroso Jarne, Herminia Lozano Gómez, Paula Abansés Moreno" "autores" => array:3 [ 0 => array:4 [ "nombre" => "Paloma Eugenia" "apellidos" => "Edroso Jarne" "email" => array:1 [ 0 => "palomaedroso@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Herminia" "apellidos" => "Lozano Gómez" ] 2 => array:2 [ "nombre" => "Paula" "apellidos" => "Abansés Moreno" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Medicina Intensiva, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Reacción transfusional a plasma hiperinmune en pacientes con infección grave por COVID-19" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Following the first wave of COVID-19 infections in spring 2020, treatment optimization studies did not provide conclusive evidence of clinical efficacy in patients with severe pneumonia.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Since mid-June, numerous outbreaks of the SARS-CoV-2 disease have hit some areas of Spain. In Aragon, infections continue to increase and account for 33% of COVID-19 hospitalizations throughout the country.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> Currently there is still no vaccine available and the interest in achieving passive immunization in the population has placed convalescent plasma and hyperimmune globulin as valid options when it comes to achieving this goal.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> Convalescent or hyperimmune plasma is extracted from patients infected by COVID-19 who have overcome the disease and have generated antibodies in sufficient titers against this pathogen which, when infused into the recipient, promote binding with the virus and facilitate its phagocytosis. Hyperimmune plasma transfusion allows for faster immunization in infected individuals and thus shorten the disease or reduce its symptoms, so it should be administered in the first days of progression.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> Like all other blood products, hyperimmune plasma can be responsible for transfusion reactions, including allergic and anaphylactic reactions, haemolysis, circulatory overload, and transfusion-related acute lung injuries. Based on published data, the incidence of serious adverse reactions to date is low (<1%).<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">We report the case of two young male patients admitted to the intensive care unit (ICU) for severe bilateral pneumonia after COVID-19 infection who had a transfusion reaction after the administration of hyperimmune plasma against COVID-19.</p><p id="par0015" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Case 1.</span> 48-year-old male from Colombia with symptoms compatible with COVID-19 infection and positive PCR. He went to the emergency department due to respiratory distress and was admitted to the ward, where he developed respiratory deterioration, for which he was transferred to the ICU. Treatment was initially started with remdesivir 200 mg and then 100 mg every 24 h and dexamethasone 20 mg every 24 h. Two bags of hyperimmune plasma were administered, after which he presented an urticarial reaction on the face and trunk along with increased dyspnoea and desaturation, requiring an increase in oxygen concentration and flow. Treatment with dexchlorpheniramine 5 mg every 8 h was started and the lesions disappeared after 24 h. The patient showed good subsequent progression, high-flow oxygen therapy (HFOT) was withdrawn, and he was discharged to the ward.</p><p id="par0020" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Case 2.</span> 45-year-old male from Cameroon. He went to the emergency department due to clinical worsening in the context of SARS-CoV-2 infection. He was admitted to the ward, where he showed a poor progression requiring admission to the ICU. Treatment started with HFOT and dexamethasone 20 mg every 24 h, remdesivir (200 mg load dose and 100 mg every 24 h later) and hyperimmune plasma, developing itchy hives in the body that subsided with 10 mg of IV dexchlorpheniramine. The course was favourable, and he was discharged.</p><p id="par0025" class="elsevierStylePara elsevierViewall">Hyperimmune plasma treatment is a promising option in the treatment of severe COVID-19 pneumonia. The allergic reaction after its administration is uncommon, and the possible relationship with the different antigenic loads of the administered plasma and the severity of the immune reaction is so far unknown.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Edroso Jarne PE, Lozano Gómez H, Abansés Moreno P. Reacción transfusional a plasma hiperinmune en pacientes con infección grave por COVID-19. Med Clin (Barc). 2021;156:306.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:4 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Uso de plasma de convalecientes para tratamiento de COVID-19 Historia y evidencia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. McAllister" 1 => "A. Mantegazza" 2 => "F. Garzón" 3 => "V. Rotbaum" 4 => "G. Remondinon" 5 => "M. Vazquez Larsson" ] ] ] ] ] "host" => array:2 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "MEDICINA (Buenos Aires)" "fecha" => "2020" "volumen" => "80" "paginaInicial" => "82" "paginaFinal" => "86" ] ] 1 => array:1 [ "WWW" => array:1 [ "link" => "https://www.medicinabuenosaires.com/indices-de-2020/volumen-80-ano-2020-s-3-indice/usoplasma/" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Transfusión de plasma convaleciente de pacientes con COVID-19: Propuesta de la Sociedad Peruana de Inmunología y la Asociación Médica Peruana de Patología Clínica para su implementación en nuestro país" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "C. Galván" 1 => "C. Toribio-Dionicio" 2 => "M. Álvarez-Ángeles" 3 => "O. Alama-Bazán" 4 => "L. Sánchez-Ramírez" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "WWW" => array:2 [ "link" => "https://preprints.scielo.org/index.php/scielo/preprint/view/545/691" "fecha" => "2020" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Coronavirus disease 2019 (COVID-19): Convalescent plasma and hyperimmuneglobulin" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "E.M. Bloch" 1 => "S. Kleinman" 2 => "J. Tirnauer" 3 => "A.M. Feldweg" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "WWW" => array:2 [ "link" => "https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-convalescent-plasma-and-hyperimmune-globulin/print?source=relatedlink" "fecha" => "2020" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.J. Joyner" 1 => "K.A. Bruno" 2 => "S.A. Klassen" 3 => "K.L. Kunze" 4 => "P.W. Johnson" 5 => "E.R. Lesser" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.mayocp.2020.06.028" "Revista" => array:3 [ "tituloSerie" => "Mayo Clin Proc" "fecha" => "2020" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29937049" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/23870206/0000015600000006/v1_202103200954/S2387020621000723/v1_202103200954/en/main.assets" "Apartado" => array:4 [ "identificador" => "43309" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23870206/0000015600000006/v1_202103200954/S2387020621000723/v1_202103200954/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020621000723?idApp=UINPBA00004N" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 October | 5 | 0 | 5 |
| 2024 September | 11 | 0 | 11 |
| 2024 August | 13 | 0 | 13 |
| 2024 July | 6 | 0 | 6 |
| 2024 June | 2 | 0 | 2 |
| 2024 May | 4 | 0 | 4 |
| 2024 April | 4 | 0 | 4 |
| 2024 March | 6 | 0 | 6 |
| 2024 February | 5 | 0 | 5 |
| 2024 January | 5 | 0 | 5 |
| 2023 December | 5 | 0 | 5 |
| 2023 November | 10 | 0 | 10 |
| 2023 October | 8 | 0 | 8 |
| 2023 September | 5 | 0 | 5 |
| 2023 August | 3 | 0 | 3 |
| 2023 July | 3 | 0 | 3 |
| 2023 June | 9 | 2 | 11 |
| 2023 May | 1 | 0 | 1 |
| 2023 April | 11 | 0 | 11 |
| 2023 March | 1 | 0 | 1 |
| 2023 February | 6 | 0 | 6 |
| 2023 January | 3 | 0 | 3 |
| 2022 December | 7 | 0 | 7 |
| 2022 November | 4 | 0 | 4 |
| 2022 October | 6 | 0 | 6 |
| 2022 September | 15 | 0 | 15 |
| 2022 August | 14 | 0 | 14 |
| 2022 July | 8 | 2 | 10 |
| 2022 June | 10 | 2 | 12 |
| 2022 May | 15 | 2 | 17 |
| 2022 April | 22 | 0 | 22 |
| 2022 March | 12 | 0 | 12 |
| 2022 February | 34 | 0 | 34 |
| 2022 January | 36 | 0 | 36 |
| 2021 December | 30 | 0 | 30 |
| 2021 November | 27 | 0 | 27 |
| 2021 October | 99 | 4 | 103 |
| 2021 September | 50 | 2 | 52 |
| 2021 August | 16 | 1 | 17 |
| 2021 July | 12 | 0 | 12 |
| 2021 June | 3 | 0 | 3 |
| 2021 May | 4 | 0 | 4 |
Show all
